Premium
STUDY OF THE EFFECTS OF BROMOCRIPTINE ON SEXUAL IMPOTENCE
Author(s) -
AMBROSI B.,
BARA ROSSELLA,
TRAVAGLINI P.,
WEBER GIOVANNA,
PECCOZ P. BECK,
RONDENA M.,
ELLI R.,
FAGLIA G.
Publication year - 1977
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.1977.tb03351.x
Subject(s) - bromocriptine , prolactin , medicine , endocrinology , testosterone (patch) , placebo , serotonergic , sexual function , dopaminergic , hormone , sexual dysfunction , dopamine , serotonin , alternative medicine , receptor , pathology
SUMMARY Serum testosterone, prolactin, LH, FSH and plasma 17β‐oestradiol levels were determined in forty‐seven male patients with sexual impotence. Low testosterone values and slightly elevated prolactin levels were observed in 19% and in 17% of cases, respectively. Since sexual function in the male seems to be controlled by both dopaminergic stimulatory and serotoninergic inhibitory mechanisms, bromocriptine was given orally to seventeen patients. As the preliminary results appeared encouraging, a double blind study was undertaken in the other thirty patients. No appreciable difference in hormonal pattern was noticed between bromocriptine and placebo treatment. As far as sexual function was concerned, good results were obtained in 52% of cases treated with bromocriptine and in 44% of patients given placebo.